APA

Dillman R. O., Nayak S. K., Barth N. M., DeLeon C., Schwartzberg L. S., Spitler L. E., Church C., O'Connor A. A. & Beutel L. D. (20000706). Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma. : Cancer biotherapy & radiopharmaceuticals.

Chicago

Dillman R O, Nayak S K, Barth N M, DeLeon C, Schwartzberg L S, Spitler L E, Church C, O'Connor A A and Beutel L D. 20000706. Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma. : Cancer biotherapy & radiopharmaceuticals.

Harvard

Dillman R. O., Nayak S. K., Barth N. M., DeLeon C., Schwartzberg L. S., Spitler L. E., Church C., O'Connor A. A. and Beutel L. D. (20000706). Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma. : Cancer biotherapy & radiopharmaceuticals.

MLA

Dillman R O, Nayak S K, Barth N M, DeLeon C, Schwartzberg L S, Spitler L E, Church C, O'Connor A A and Beutel L D. Clinical experience with autologous tumor cell lines for patient-specific vaccine therapy in metastatic melanoma. : Cancer biotherapy & radiopharmaceuticals. 20000706.